A Foundation for Lab Digitalization and Automation
This BIOVIA customer is one of the world’s largest companies engaged in the research, production and distribution of pharmaceutical, consumer healthcare and vaccine products. The growing complexity and diversity of their expanding product lines, as well as the acceleration of clinical trial processes, has put their Chemistry, Manufacturing and Controls (CMC) organization on the critical path for commercial product launches.
The company accepted the challenge to implement a common solution across all CMC labs and for all therapeutic modalities—both small molecules and biologics. Built with BIOVIA Dassault Systèmes’ ONE Lab solution, the project provides a common platform for use across all drug substance, drug product and analytical development labs worldwide.
Download the use case to learn more.